Company: AOSL
Filing Date: 2025-09-18
Form Type: DEF 14A
Source: 0001387467-25-000054
Chunk: 66

Company: ALPHA & OMEGA SEMICONDUCTOR Ltd
Filing Date: 2025-09-18
Form: DEF 14A
Chunk 66
---
| XProvide tax gross-ups except in connection with certain perquisites                               |     | XProvide excessive perquisites                                                     |
| XTime the release of material non-public information to affect the value of executive compensation |     |                                                                                    |

#### CEO Post-Vesting Holding Requirement
For full value awards (i.e., share awards, performance share awards, restricted share units, and performance share units) granted to our Chief Executive Officer beginning on or after August 7, 2025, there is a one-year post-vesting holding requirement that requires the Chief Executive Officer to hold at least fifty percent (50%) of the common shares issued to the Chief Executive Officer under such full value awards (i.e., share awards, performance share awards, restricted share units, and performance share units), net of any common shares withheld to cover applicable taxes, for a period of one-year following the vesting date (the “Holding Period”). However, the Holding Period will not apply after a change in control, termination of service, or the date of the Chief Executive Officer’s death or disability. This post-vesting Holding Period, along with the common share ownership requirement described below, focuses the Chief Executive Officer on the long-term success of the Company and further aligns the executive officer’s interests with those of our shareholders.

#### Impact of 2024 Say-on-Pay Vote
We held our last “say on pay” vote in 2024 and approximately 97.8% of the total votes cast on such proposal were in favor of the compensation of the named executive officers, as that compensation was disclosed in the Compensation Discussion and Analysis and the various compensation tables and narrative that appeared in the Company’s proxy statement dated September 18, 2025. Based on that high level of shareholder approval, the Compensation Committee decided not to make any material changes to the Company’s compensation philosophies, policies and practices for the fiscal year 2025 compensation of the named executive officers.

The Compensation Committee will continue to take into account future shareholder advisory votes on executive compensation and other relevant market developments affecting executive officer compensation in order to determine whether any subsequent changes to the Company’s executive compensation programs and policies would be warranted to reflect any shareholder concerns reflected in those advisory votes or to address market developments.

<div align='center'>39</div>

#### Compensation Decision-Making Process
The Compensation Committee meets on a regular schedule throughout the year to manage our compensation programs. The Compensation Committee reviews the principal components of compensation for our executive officers on an annual basis, typically at its first meeting